NewAmsterdam Pharma Company N.V. Warrant (NASDAQ: NAMSW) last traded at $16.51, up 0.00% on the session. The quote above updates while this page is open; the figures below are drawn from NewAmsterdam Pharma Company N.V. Warrant’s own filings and are restated only when a new one is published.
NewAmsterdam Pharma Company N.V. Warrant trades on NASDAQ under the ticker NAMSW. Its market capitalisation is $1.97 billion.
Valuation measures for NewAmsterdam Pharma Company N.V. Warrant, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.97B |
|---|---|
| Enterprise value | $1.62B |
| Price / sales | 277.15 |
| Price / book | 3.13 |
| Beta | 0.54 |
Trailing-twelve-month figures tagged in NewAmsterdam Pharma Company N.V. Warrant's XBRL filings with the SEC.
| Revenue (TTM) | $7.12M |
|---|---|
| Net income (TTM) | -$259.50M |
| EPS (TTM) | -$2.15 |
| Operating margin | -3432.20% |
| Return on equity | -41.10% |
| Cash | $424.15M |
Range and volume for NAMSW over the past 52 weeks.
| 52-week high | $30.45 |
|---|---|
| 52-week low | $12.67 |
| Volume | 211 |
| Average volume | 2.4K |
| Previous close | $16.51 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.